SCHEMBL17464288

SCHEMBL17464288

CON(C)C(=O)C1CN(B(C)O)CCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL415332 0.81 — —
SCHEMBL12879227 0.77 MAPT (0.30) —
SCHEMBL10202903 0.77 — —
SCHEMBL14699492 0.77 KDM2B (0.30) —
SCHEMBL19798957 0.75 BCHE (0.35) —
SCHEMBL13391543 0.73 — —
SCHEMBL20052041 0.72 — —
SCHEMBL14697656 0.72 HPGD (0.42) —
SCHEMBL14697193 0.70 EPHX1 (0.48) —
SCHEMBL15329099 0.69 CHRM2 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160024121-A1 BETA-LACTAMASE INHIBITORS VenatoRx Pharmaceuticals, Inc. 2016-01-28 — — US disclosed
Send feedback